Hassan Imran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hassan Imran has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Faryal Javed
Riphah International University, Lahore, Pakistan
1 shared publicationHumayun Riaz
Rashid Latif College of Pharmacy, Lahore (RLKU), Pakistan
1 shared publication- Misbah Sultana
Research Center, RAK College of Dental Sciences, RAK Medical and Health Sciences University, Ras Al-Khaimah P.O. Box 12973, United Arab Emirates
1 shared publication Muhammad Maaz Ali
Beacon House College, University Road, Sargodha, Pakistan
1 shared publicationRuqaiya Rasheed Kayani
Riphah International University, Lahore, Pakistan
1 shared publicationSaba Manzoor
Fazal Din Pharma Plus, Lahore, Pakistan
1 shared publication
Latest Publications
- Open Access
- 24 September 2022
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- p. 42-50
Role of Herbal Medicines in Hepatocellular Carcinoma
Mutation in several factors and pathways leads to the development of hepatic cancer i.e. Mutation in Wnt-β-Catenin Signalling Pathway , activation of the Insulin-Like Growth Factor (IGF) Signalling Pathway, The P13/PTEN/AKT, TP53 Tumour Suppressor Gene. Liver cirrhosis and fatty liver predispose the normal tissues to fibrosis leading to liver cancer. Excessive alcohol intake results in the inflammation of liver proceeding to cirrhosis and ultimately hepatic carcinoma. Hepatocellular Carcinoma (HCC) is multi-centric i.e. has huge variability in its spread which differs from person to person. Four approaches are practiced for treatment of hepatic cancer; surgery, transarterial intervention, percutaneous intervention, and drug approach. Surgery includes liver transplant and tumour resection. Transarterial approach includes chemoembolization and embolization. Percutaneous approach includes radiofrequency thermal ablation (RFTA) and ethanol injection. Drugs are various including herbal plant medicines, herbal formulae, synthetic drugs, immune, and gene therapies. Zingiber officinal, Schinus molle L., Zerumbone, Curcuma longa and Mammea siamensis are some of the plant medicines.
- 24 September 2022
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- p. 42-50
Open AccessRole of Herbal Medicines in Hepatocellular Carcinoma
Mutation in several factors and pathways leads to the development of hepatic cancer i.e. Mutation in Wnt-β-Catenin Signalling Pathway , activation of the Insulin-Like Growth Factor (IGF) Signalling Pathway, The P13/PTEN/AKT, TP53 Tumour Suppressor Gene. Liver cirrhosis and fatty liver predispose the normal tissues to fibrosis leading to liver cancer. Excessive alcohol intake results in the inflammation of liver proceeding to cirrhosis and ultimately hepatic carcinoma. Hepatocellular Carcinoma (HCC) is multi-centric i.e. has huge variability in its spread which differs from person to person. Four approaches are practiced for treatment of hepatic cancer; surgery, transarterial intervention, percutaneous intervention, and drug approach. Surgery includes liver transplant and tumour resection. Transarterial approach includes chemoembolization and embolization. Percutaneous approach includes radiofrequency thermal ablation (RFTA) and ethanol injection. Drugs are various including herbal plant medicines, herbal formulae, synthetic drugs, immune, and gene therapies. Zingiber officinal, Schinus molle L., Zerumbone, Curcuma longa and Mammea siamensis are some of the plant medicines.